Is cephalexin (Keflex) appropriate for treating a bacterial throat infection in an adult without a severe penicillin allergy, and what is the recommended dosing regimen?

Cephalexin (Keflex) for Throat Infection

Cephalexin is appropriate for bacterial throat infections ONLY if the patient has a penicillin allergy without anaphylaxis history, but it is NOT the first-line choice for adults without penicillin allergy. 1

First-Line Treatment Algorithm

For confirmed Group A Streptococcal (GAS) pharyngitis (the primary bacterial cause of throat infections):

If NO Penicillin Allergy:

• Use penicillin V or amoxicillin - these are the recommended first-line agents due to narrow spectrum, low adverse effects, and low cost 1
• Penicillin V: 500 mg twice daily for 10 days (adults)
• Amoxicillin: 1000 mg once daily for 10 days (adults)

If Penicillin Allergy (Non-Anaphylactic):

• Cephalexin is appropriate: 500 mg twice daily for 10 days 1, 2
• Alternative dosing: 20 mg/kg/dose twice daily (max 500 mg/dose) 1
• Critical caveat: Avoid cephalexin in patients with immediate-type hypersensitivity (anaphylaxis) to penicillin 1

If Anaphylactic Penicillin Allergy:

• Use clindamycin, clarithromycin, or azithromycin instead 1

Evidence Quality and Reasoning

The 2012 IDSA guidelines provide strong, high-quality evidence that penicillin/amoxicillin should be first-line for GAS pharyngitis 1. Cephalexin receives a strong recommendation with high-quality evidence specifically for penicillin-allergic patients without anaphylaxis 1.

Why cephalexin works but isn't first-line:

• Cephalexin demonstrates 87-93% bacteriologic cure rates for streptococcal pharyngitis 3, 4
• Some studies show cephalexin may be slightly more effective than penicillin (10% vs 19% combined failure rates) 5
• However, broader spectrum increases resistance risk and unnecessary exposure 1

Cross-Reactivity Risk

The cross-reactivity concern is overstated for most patients: Meta-analysis shows first-generation cephalosporins like cephalexin have increased allergic reaction risk in penicillin-allergic patients (OR 5.8), but this is primarily in patients with amino-penicillin allergies (amoxicillin/ampicillin) due to shared R1 side chains 6, 7. For other penicillin allergies, the risk is substantially lower, and severe cross-reactivity is extremely rare 7.

Dosing Regimen (FDA-Approved)

Adults: 2

• Standard: 500 mg every 12 hours for 10 days
• Alternative: 250 mg every 6 hours for 10 days
• For streptococcal pharyngitis specifically, the 500 mg twice-daily regimen is explicitly approved 2

Pediatric (>1 year): 2

• 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days
• Can divide total daily dose (25-50 mg/kg/day) every 12 hours for streptococcal pharyngitis 2

Critical Pitfalls to Avoid

1. Don't use cephalexin empirically without confirming bacterial infection - most sore throats are viral 1. Test with rapid antigen detection test (RADT) or throat culture first.

2. Don't use in anaphylactic penicillin allergy - the cross-reactivity risk, while low, is not zero 1, 6

3. Don't use shorter courses - 10 days is required to prevent rheumatic fever and ensure eradication 1, 2

4. Don't assume all throat infections need antibiotics - only GAS pharyngitis benefits from treatment 1. Viral features (cough, rhinorrhea, hoarseness, oral ulcers) argue against bacterial infection 1.

5. Geographic resistance matters - while not prominent for cephalexin, be aware of local resistance patterns 1

When Cephalexin Is Reasonable

• Documented GAS pharyngitis with non-anaphylactic penicillin allergy
• Patient adherence concerns favor twice-daily over four-times-daily penicillin V
• Previous treatment failure with penicillin (though this may indicate carrier state rather than true failure) 1